
|Articles|May 11, 2022
Emmes Launches Third Generation Version of Advantage eClinical
Advertisement
Emmes has announced the launch its third generation version of Advantage eClinical. The cloud platform will be available as a standalone software product after undergoing more than two years of development. The system has been specifically designed to provide fast study builds, greater flexibility, and insights to clinical trial sponsors of all sizes.
Read more about the launch
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data
3
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
4
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
5



